Latest News about HCM
Recent news which mentions HCM
Xi’s power move punishes Chinese stocks, pushing them down as much as 26% in one day
October 24, 2022
From MarketWatch
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 24, 2022
From Benzinga
Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday
September 22, 2022
From Benzinga
Nikola, Super Micro Computer And Other Big Losers From Monday
September 20, 2022
From Benzinga
Groupon, Spectrum Brands, Adobe And Other Big Losers From Thursday
September 16, 2022
From Benzinga
HUTCHMED Cancer Med Cuts Death Risk By 34% In Metastatic Colorectal Cancer
September 08, 2022
Tickers
HCM
From Benzinga
7 Chinese Stocks to Sell While You Still Can
September 02, 2022
Tags
PNGAY
OTCMKTS:TCEHY,NASDAQ:JD,NYSE:SOS,OTCMKTS:LGFRY,OTCMKTS:PNGAY,NASDAQ:HCM,NASDAQ:BGNE
Stocks to Sell
From InvestorPlace
Recap of Tuesday's Biotech Catalysts - End Of the Day Summary
August 09, 2022
From Benzinga
Recap of Monday's Biotech Catalysts - End Of the Day Summary
August 08, 2022
From Benzinga
AstraZeneca's Tagrisso Doublet Therapy Shows 49% Response Rate In Lung Cancer Setting
August 08, 2022
From Benzinga
Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
August 01, 2022
From Benzinga
From Benzinga
From Benzinga
Black patients were rarely included in clinical trials — until the COVID-19 vaccines. Will these changes stick?
June 30, 2022
From MarketWatch
83 Biggest Movers From Yesterday
June 09, 2022
From Benzinga
From Benzinga
38 Stocks Moving In Friday's Mid-Day Session
May 20, 2022
From Benzinga
20 Stocks Moving in Friday's Pre-Market Session
May 20, 2022
From Benzinga
76 Biggest Movers From Yesterday
May 19, 2022
From Benzinga
From Benzinga
HFCAA News: 128 Chinese Stocks the SEC Could Delist
May 05, 2022
From InvestorPlace
66 Biggest Movers From Yesterday
May 03, 2022
From Benzinga
From Benzinga
31 Stocks Moving In Monday's Mid-Day Session
May 02, 2022
From Benzinga
From Benzinga
U.S. FDA Rejects HUTCHMED's New Drug Application For Surufatinib In Neuroendocrine Tumors
May 02, 2022
Tickers
HCM
From Benzinga
From Benzinga
From Benzinga
7 Biotech Stocks to Buy With Key Catalysts for April
April 05, 2022
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.